COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

Comparative Trial Evaluating Safety and Immunogenicity of an Adjuvanted and a Conventional Influenza Vaccine in Elderly Subjects (> 60 Years)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00310648
Recruitment Status : Completed
First Posted : April 4, 2006
Last Update Posted : September 14, 2006
Novartis Vaccines
Chiron s.r.l. Beijing Representative Office
Information provided by:

No Study Results Posted on for this Study
Recruitment Status : Completed
Primary Completion Date : No date given
Study Completion Date : No date given